Shining a light on bile duct cancer: new combination therapy trial
NCT ID NCT07398339
Summary
This study is testing whether a new light-activated drug, used with standard chemotherapy, can help people with advanced bile duct cancer that has caused a blockage. The treatment involves injecting a drug that makes cancer cells sensitive to light, then using a special light to activate it inside the bile ducts. Researchers want to see if this combination helps patients live longer and controls the cancer better than current options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCERS (BTC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 266, Trumpet Vine Road
RECRUITINGShanghai, Pudong New Area, 200120, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.